The Enterprisers
-
What Impact Is The Inflation Reduction Act Already Having On Biopharma Companies, And What More Can The Industry Do Going Forward?
9/1/2023
See the answer from Stephen Rapundalo, president and CEO of MichBio.
-
Leading With Authenticity
9/1/2023
While in my last corporate job at a Fortune 100 company, I realized the kind of leader I would be; I would be me — authentic, kind, collaborative, purpose-driven, and empowering.
-
Biotech Needs To Pay More Attention To Data-Privacy Laws
9/1/2023
Biotech professionals are already familiar with the complex regulatory environment surrounding healthcare, medical innovations, and clinical trials, and have developed departments, policies and procedures to comply with them. Yet like many other industries, the biotech industry is playing catch-up when it comes to constantly expanding global privacy regulations.
-
Strategic Business Pivoting For Cell & Gene Startups
9/1/2023
Understanding the different types of pivots and when to use them can increase the chances of success for any life sciences company.
-
Why It’s Imperative To Improve Your Program Governance
9/1/2023
Organizations developing pharmaceuticals must leverage a more flexible style of project management that adapts throughout the product life cycle and promotes cross-functional operations to accelerate speed to market, optimizing economic performance and patient access to care. Here are three paths pharma companies can take to improve their project management outputs.
-
Addressing The Uncertainties Of The IRA In Biopharma
9/1/2023
In recent years, the biopharma industry has been anything but predictable. But the creation of the Inflation Reduction Act (IRA) of 2022 has added a new layer of uncertainty that reaches most corners of the industry.
-
Taking A Fresh Approach To Finance At BMS
9/1/2023
A rising star in BMS’s finance department, Tatiana Simonelli, SVP, finance commercialization at BMS discusses her path to senior leadership, and how talent diversity can boost business results.
-
The DEI Value Proposition
9/1/2023
The value of DEI initiatives sometimes get lost in their feel-good, altruistic intent. Not at Rocket Pharmaceuticals, where purposeful and specific equity and inclusion exercises pay dividends in the form of a diverse, talented, and committed workforce. President & COO Kinnari Patel, PharmD explains.
-
How Can Executives Work Through Tightened Budgets And Manage Tradeoffs While Keeping The Workforce Happy And Motivated?
9/1/2023
See the answer from Tim Wright, chairman of the board of directors at Isosceles Pharmaceuticals.
-
Successfully Launching Drugs In Europe On Time And On Budget
9/1/2023
In this article, Margarida Duarte of Deciphera Pharmaceuticals shares insights from her recent experience with launching a new oncology drug in Europe.